Navigation Links
Avantium and BP Extend Strategic Partnership

AMSTERDAM, October 16 /PRNewswire/ -- Avantium, a leading technology company servicing the oil, chemicals and pharmaceutical industries, announces the three-year extension of the strategic research collaboration with BP, one of the world's largest energy companies.

Avantium provides innovative, high value-added R&D services and tools to the energy, chemicals and pharmaceutical industries, and has a long standing relationship with BP. The collaboration builds on the strategic relationship between BP and Avantium that was initiated in 2005. The strategic research collaboration in the area of purified terephthalic acid (PTA) is extended for a period of 3 years. During this period Avantium will apply its advanced high-throughput R&D technology, services and modeling capabilities in the research and technology portfolio of BP's PTA business.

Tom van Aken, Chief Executive Officer of Avantium: "We are very pleased to continue our strategic relationship with BP. Over the past years, the teams of BP and Avantium have successfully collaborated to apply our unique technological capabilities to BP's PTA business. The continuation of our joint efforts is an excellent proof of the added value of our technology and expertise."

Sue Davison, Business Technology Manager BP Aromatics and Acetyls: "This strategic collaboration with Avantium is consistent with BP's global technology position in PTA, and affirms our commitment to continue to employ leading technologies such as high-throughput R&D for continual improvement of our PTA business."

Profile Avantium

Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology. Avantium has demonstrated the potential of this technology by providing R&D services and tools to more than 70 companies worldwide, including many of the world's largest energy, chemicals and pharmaceutical companies. Avantium has approximately 100 employees; its offices and head quarters are based in Amsterdam.

Other information

This release may contain certain forward-looking statements relating to the business, financial performance and results of Avantium and the industry in which it operates. These statements are based on its current plans, estimates and projections, as well as its expectations of external conditions and events. A number of important factors, and the inherent risks and uncertainties that such statements involve, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements.

In the event of any inconsistency between an English version and a Dutch version of this document, the English version will prevail over the Dutch version.

For further information:


SOURCE Avantium Technologies B.V.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. Liver key to extending life
3. Regular exercise linked to extended menstrual cycles
4. Even mid-life diet change can extend life
5. Extended Therapy for Blood Clots
6. Friendship can extend lifespan
7. Genes to Extend Longevity Discovered
8. India extends National TB Control Program
9. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
10. Drug Courts In Europe Extended For Three More Years
11. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... 2015 , ... Many people know of the common symptoms of low thyroid ... skin. But many people who find their cholesterol levels and weight are creeping up ... especially if they don’t have any of the other symptoms. , Thyroid hormone plays ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for Tuberous Sclerosis Complex (TSC), as well as raising public awareness of the ... they need it—presented a third donation of $35,000 to bolster progress at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to ... of the Create Real Impact awards. California Casualty is proud to support ... tide of distracted and reckless driving, the number one killer of young drivers. ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... November 25, 2015 Developmental, commercial, ... boosting the profitability of pharmaceutical products, says GBI ... and regulatory/legal strategies all play a key role ... GBI Research . --> Developmental, ... key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology: